This article discusses the TTAB's decision in Bayer regarding how and when a foreign trademark can be used.
Related Professionals
-
Partner and National Co-Chair, Trademark/Copyright/Privacy Group+1.212.940.8554
-
Related Practices
Related Industries
Related Offices
Recent Articles
-
$885M IBS Drug Verdict Tests Pay-For-Delay Limits
June 30, 2026
-
Recent Cases Clarify When Risk Disclosures Trigger Liability
June 24, 2026
-
AI Deals Call For Tailored Approach To Address Hidden Risks
June 18, 2026